Abstract
This document provides guidance to manufacturers on the minimal considerations for in vitro diagnostic (IVD) medical devices in a public health crisis: - general considerations; - risk reduction; - monitoring the devices’ post-market performance and quality assurance; - implementing a communication system. This document does not supersede the existing traditional regulatory authorization requirements for IVD medical devices available in the marketplace.
General information
-
Status: Under developmentPublication date: 2024-11Stage: International Standard under publication [60.00]
-
Edition: 1
-
Technical Committee :ISO/TC 212ICS :11.100.10
- RSS updates